Literature DB >> 7920170

Management of early oral cavity cancer. Experience of Centre Oscar Lambret.

J L Lefebvre1, B Coche-Dequeant, E Buisset, X Mirabel, J T Van, B Prevost.   

Abstract

From 1974 to 1983, 579 patients presenting with early oral cancer (excluding lip tumours) were treated at Centre Oscar Lambret. Of these, 429 were treated locally by brachytherapy with local control achieved in 82% of the cases (90% after salvage surgery). Treatment-related complications occurred in 19% of the cases, requiring surgical management in 13 patients. In contrast, only 51% of the 35 patients treated by external radiotherapy and brachytherapy were controlled, resulting in a poor 5-year survival (14%). Results for the 24 patients treated surgically were similar to those of brachytherapy alone. Finally, for T1 T2 N0 patients, the advantages of an elective neck dissection are not clear and could be clarified by a randomised trial. Indeed, this retrospective study failed to find a significant difference in the incidence of death due to an uncontrolled neck evolution whatever the neck management.

Entities:  

Mesh:

Year:  1994        PMID: 7920170     DOI: 10.1016/0964-1955(94)90095-7

Source DB:  PubMed          Journal:  Eur J Cancer B Oral Oncol        ISSN: 0964-1955


  3 in total

1.  Reproduction of occult metastasis of head and neck cancer in nude mice.

Authors:  S Kawashiri; S Kumagai; K Kojima; H Harada; K Nakagawa; E Yamamoto
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

2.  Clinical outcomes for T1-2N0-1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapy.

Authors:  Su Jung Shim; Jihye Cha; Woong Sub Koom; Gwi Eon Kim; Chang Geol Lee; Eun Chang Choi; Ki Chang Keum
Journal:  Radiat Oncol       Date:  2010-05-27       Impact factor: 3.481

3.  An expression analysis of markers of radiation-induced skin fibrosis and angiogenesis in wound healing disorders of the head and neck.

Authors:  Steffen Koerdt; Nils H Rohleder; Niklas Rommel; Christopher Nobis; Mechthild Stoeckelhuber; Steffi Pigorsch; Marciana-Nona Duma; Klaus-Dietrich Wolff; Marco R Kesting
Journal:  Radiat Oncol       Date:  2015-09-22       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.